1. GPCR/G Protein
    Neuronal Signaling
  2. GPR119


GPR119 (G protein-coupled receptor 119) is a G protein-coupled receptor that in humans is encoded by the GPR119 gene. GPR119, along with GPR55 and GPR18, have been implicated as novel cannabinoid receptors. GPR119 is expressed predominantly in the pancreas and gastrointestinal tract in rodents and humans, as well as in the brain in rodents. Activation of the receptor has been shown to cause a reduction in food intake and body weight gain in rats. GPR119 has also been shown to regulate incretin and insulin hormone secretion. As a result, new drugs acting on the receptor have been suggested as novel treatments forobesity and diabetes.

GPR119 Related Products (6):

Cat. No. Product Name Effect Purity
  • HY-15564
    AR 231453 Agonist 99.84%
    AR 231453 is a potent, selective and orally available GPR119 agonist.
  • HY-15566
    APD597 Agonist 99.97%
    APD597 is a GPR119 agonist intended for the treatment of type 2 diabetes, with EC50 of 46 nM for hGPR119.
  • HY-15291
    MBX-2982 Agonist 99.54%
    MBX-2982 is a selective, orally-available G protein-coupled receptor 119 (GPR119) agonist.
  • HY-15565
    APD668 Agonist 99.71%
    APD668 is a potent GPR119 agonist with EC50 of 2.7 nM and 33 nM for hGPR119 and ratGPR119 respectively.
  • HY-12066
    GSK1292263 Agonist 99.71%
    GSK1292263 is a novel GPR119 receptor agonist used for the treatment of type 2 diabetes.
  • HY-16673
    PSN632408 Agonist 99.91%
    PSN632408 is an optimized agonist of GPR119 receptors that shows similar potency to OEA at both recombinant mouse and human GPR119 receptors, exhibiting EC50 values of 5.6 and 7.9 uM, respectively.